Print

ProSensa B.V. to Present at J.P. Morgan Healthcare Conference  
1/3/2013 6:30:47 AM

Prosensa, the private Dutch biopharmaceutical company focusing on RNA-modulating therapeutics for rare diseases with high unmet need, today announced that Hans Schikan, Chief Executive Officer, will be presenting at the 31st Annual J.P. Morgan Healthcare Conference in San Francisco.
//-->